title: Update: Influenza Activity - United States, October 2-December 17, 2016.
abstract: This report summarizes U.S. influenza activity*during October 2-December 17, 2016.†Influenza activity in the United States remained low in October and has been slowly increasing since November. Influenza A viruses were identified most frequently, with influenza A (H3N2) viruses predominating. Most influenza viruses characterized during this period were genetically or antigenically similar to the reference viruses representing vaccine components recommended for production in the 2016-17 Northern Hemisphere influenza vaccines.
authors.forename: Mei
authors.initials: M
authors.lastname: Shang
authors.forename: Lenee
authors.initials: L
authors.lastname: Blanton
authors.forename: Krista
authors.initials: K
authors.lastname: Kniss
authors.forename: Desiree
authors.initials: D
authors.lastname: Mustaquim
authors.forename: Noreen
authors.initials: N
authors.lastname: Alabi
authors.forename: Stephen
authors.initials: S
authors.lastname: Barnes
authors.forename: Alicia
authors.initials: A
authors.lastname: Budd
authors.forename: Stacy L
authors.initials: SL
authors.lastname: Davlin
authors.forename: Natalie
authors.initials: N
authors.lastname: Kramer
authors.forename: Shikha
authors.initials: S
authors.lastname: Garg
authors.forename: Charisse N
authors.initials: CN
authors.lastname: Cummings
authors.forename: Brendan
authors.initials: B
authors.lastname: Flannery
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Fry
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Grohskopf
authors.forename: Sonja J
authors.initials: SJ
authors.lastname: Olsen
authors.forename: Joseph
authors.initials: J
authors.lastname: Bresee
authors.forename: Wendy
authors.initials: W
authors.lastname: Sessions
authors.forename: Rebecca
authors.initials: R
authors.lastname: Garten
authors.forename: Xiyan
authors.initials: X
authors.lastname: Xu
authors.forename: Anwar Isa Abd
authors.initials: AI
authors.lastname: Elal
authors.forename: Larisa
authors.initials: L
authors.lastname: Gubareva
authors.forename: John
authors.initials: J
authors.lastname: Barnes
authors.forename: David E
authors.initials: DE
authors.lastname: Wentworth
authors.forename: Erin
authors.initials: E
authors.lastname: Burns
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Katz
authors.forename: Daniel
authors.initials: D
authors.lastname: Jernigan
authors.forename: Lynnette
authors.initials: L
authors.lastname: Brammer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care / Q000706:statistics & numerical data; D000998:Antiviral Agents / Q000494:pharmacology; D002648:Child; D046688:Child Mortality; D002675:Child, Preschool; D024882:Drug Resistance, Viral; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D057221:Influenza A Virus, H1N2 Subtype / Q000302:isolation & purification; D053122:Influenza A Virus, H3N2 Subtype / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D009981:Influenza B virus / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D007251:Influenza, Human / Q000453:epidemiology* / Q000401:mortality / Q000821:virology; D008875:Middle Aged; D011014:Pneumonia / Q000401:mortality; D011159:Population Surveillance; D012621:Seasons; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000998:Antiviral Agents